PINPOINT enables non-destructive nanoscopic quality control of individual lipid nanoparticles and their mRNA cargo
- 1University of Michigan (Ann Arbor)
Abstract
Quality control of lipid nanoparticles (LNPs) is central to development of mRNA therapeutics, yet ensemble measurements obscure critical heterogeneity in particle morphology and mRNA cargo loading. Here we introduce PINPOINT (Profiling Individual Nanoparticles with Precise Observation of INternalized Therapeutics), a single-particle nanoscopy platform for non-destructive, multiparametric profiling of preformulated LNP samples. Super-resolution imaging with Nile Red resolves size and morphology, while an optimized permeabilization strategy provides selective access to encapsulated mRNA without compromising LNP integrity. Single-particle fluorescence measurements, including RiboGreen and sequence-specific probes, enable quantification and validation of mRNA loading and identity. Comparative analyses of bare and encapsulated mRNA reveal kinetic and structural features, exposing heterogeneity masked by bulk assays. By integrating structural and molecular readouts at the single-particle level, PINPOINT establishes a quantitative framework for assessing of LNP composition and payload distribution, offering actionable insights for improving batch consistency and guiding the rational design of next-generation mRNA delivery systems.
Related
- Targeted Gastrointestinal Delivery of mRNA Lipid Nanoparticles Enables Systemic Vaccination and Glucagon-like Peptide-1 Metabolic Therapy.
- Nanoscopic Origin of Enhanced Tyrosine-Mediated Water Ordering over Canonical Threonine Motifs in a Bacterial Ice-Nucleating Protein
- Non-Destructive Quality Control Across the Life Cycle of Bioprinted Products
- Near-infrared spectroscopy for rapid and non-destructive assessment of PFAS effects in blue mussels (Mytilus spp.): a proof-of-concept study
- scDRP: disentangled representation learning for predicting single-cell responses to perturbations and estimating individual treatment effects
BibTeX
@misc{banerjee2026pinpoint,
title = {{PINPOINT enables non-destructive nanoscopic quality control of individual lipid nanoparticles and their mRNA cargo}},
author = {P. Banerjee and T. Chatterjee and A. Johnson-Buck and N. E. Wrubel and A. Ahnoud and N. G. Walter},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.11.758378},
url = {https://www.biorxiv.org/content/10.64898/2026.10.11.758378v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - PINPOINT enables non-destructive nanoscopic quality control of individual lipid nanoparticles and their mRNA cargo
AU - P. Banerjee
AU - T. Chatterjee
AU - A. Johnson-Buck
AU - N. E. Wrubel
AU - A. Ahnoud
AU - N. G. Walter
PY - 2026
DA - 2026/10/11
PB - bioRxiv
DO - 10.64898/2026.10.11.758378
UR - https://www.biorxiv.org/content/10.64898/2026.10.11.758378v1
AB - Quality control of lipid nanoparticles (LNPs) is central to development of mRNA therapeutics, yet ensemble measurements obscure critical heterogeneity in particle morphology and mRNA cargo loading. Here we introduce PINPOINT (Profiling Individual Nanoparticles with Precise Observation of INternalized Therapeutics), a single-particle nanoscopy platform for non-destructive, multiparametric profiling of preformulated LNP samples. Super-resolution imaging with Nile Red resolves size and morphology, while an optimized permeabilization strategy provides selective access to encapsulated mRNA without compromising LNP integrity. Single-particle fluorescence measurements, including RiboGreen and sequence-specific probes, enable quantification and validation of mRNA loading and identity. Comparative analyses of bare and encapsulated mRNA reveal kinetic and structural features, exposing heterogeneity masked by bulk assays. By integrating structural and molecular readouts at the single-particle level, PINPOINT establishes a quantitative framework for assessing of LNP composition and payload distribution, offering actionable insights for improving batch consistency and guiding the rational design of next-generation mRNA delivery systems.
SN - 2692-8205
ER -